Literature DB >> 30913399

STAT3 phosphorylation mediates high glucose-impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy.

Wei Du1, Na Wang2, Fan Li1, Keqi Jia1, Jiahui An1, Yaping Liu1, Yuxue Wang1, Lin Zhu3, Song Zhao1, Jun Hao1.   

Abstract

Schwann cells are the main supportive cells of the peripheral nerves. Schwann cells suffer inhibition of autophagy under hyperglycemia treatment in diabetic peripheral neuropathy (DPN). However, the exact mechanism is still not fully elucidated. We first observed the decrease of autophagy markers (LC3-II/LC3-I, P62) in the sciatic nerves of diabetic mice vs. normal mice, accompanied with the loss of myelinated nerve fibers and abnormal myelin sheath. In line with this, LC3-II/LC3-I and P62 were also significantly reduced in high glucose-treated rat Schwann cell 96 (RSC96) cells compared with normal glucose-treated cells. Furthermore, we found that trichostatin A [an inhibitor of histone deacetylase (HDAC)] evidently improved LC3-II/LC3-I in high glucose-treated RSC96 cells, without an effect on P62 expression. Again, HDAC1 and HDAC5 were revealed to be increased in RSC96 cells stimulated with high glucose. Inhibition of HDAC1 but not HDAC5 by small hairpin RNA vector enhanced LC3-II/LC3-I in high glucose-cultured RSC96 cells. In addition, LC3-II conversion regulators [autophagy-related protein (Atg)3, Atg5, and Atg7] were detected in high glucose-treated and HDAC1-knockdown RSC96 cells, and Atg3 was proven to be the key target of HDAC1. The presuppression of Atg3 offset the improvement of LC3-II/LC3-I resulting from HDAC1 inhibition in high glucose-treated RSC96 cells. The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway was activated in RSC96 cells treated with high glucose, which was indicated by increased STAT3 phosphorylation. Blocking STAT3 phosphorylation by chemical inhibitor AG490 induced HDAC1 down-regulation followed by increases in Atg3 and LC3-II/LC3-I. Interestingly, we also found that AG490 treatment enhanced P62 expression in high glucose-stimulated RSC96 cells. Taken together, our findings demonstrate that hyperglycemia inhibits LC3-II/LC3-I in an HDAC1-Atg3-dependent manner and decreases P62 expression in an HDAC-independent manner via the JAK-STAT3 signaling pathway in the Schwann cells of DPN.-Du, W., Wang, N., Li, F. Jia, K., An, J., Liu, Y., Wang, Y., Zhu, L., Zhao, S. Hao, J. STAT3 phosphorylation mediates high glucose-impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy.

Entities:  

Keywords:  Atg3; JAK-STAT3 signaling; LC3; P62; histone deacetylase 1

Mesh:

Substances:

Year:  2019        PMID: 30913399     DOI: 10.1096/fj.201900127R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  16 in total

1.  Lipin1 Alleviates Autophagy Disorder in Sciatic Nerve and Improves Diabetic Peripheral Neuropathy.

Authors:  Meijian Wang; Min Xie; Shuyan Yu; Pan Shang; Cong Zhang; Xiaolin Han; Cuiqin Fan; Li Chen; Xianghua Zhuang; Shihong Chen
Journal:  Mol Neurobiol       Date:  2021-08-26       Impact factor: 5.590

Review 2.  Neurobiological Opportunities in Diabetic Polyneuropathy.

Authors:  Trevor M Poitras; Easton Munchrath; Douglas W Zochodne
Journal:  Neurotherapeutics       Date:  2021-12-21       Impact factor: 6.088

3.  FBXW7 mediates high glucose‑induced SREBP‑1 expression in renal tubular cells of diabetic nephropathy under PI3K/Akt pathway regulation.

Authors:  Lisha Li; Juxiang Yang; Fan Li; Fan Gao; Lin Zhu; Jun Hao
Journal:  Mol Med Rep       Date:  2021-02-04       Impact factor: 2.952

4.  The Dawn of Mitophagy: What Do We Know by Now?

Authors:  Dmitrii M Belousov; Elizaveta V Mikhaylenko; Siva G Somasundaram; Cecil E Kirkland; Gjumrakch Aliev
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

5.  Ablation of dynamin-related protein 1 promotes diabetes-induced synaptic injury in the hippocampus.

Authors:  Gyeongah Park; Jong Youl Lee; Hye Min Han; Hyeong Seok An; Zhen Jin; Eun Ae Jeong; Kyung Eun Kim; Hyun Joo Shin; Jaewoong Lee; Dawon Kang; Hyun Joon Kim; Yong Chul Bae; Gu Seob Roh
Journal:  Cell Death Dis       Date:  2021-05-05       Impact factor: 8.469

6.  METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease.

Authors:  Zhaoxia Xu; Keqi Jia; Hui Wang; Feng Gao; Song Zhao; Fan Li; Jun Hao
Journal:  Cell Death Dis       Date:  2021-01-04       Impact factor: 8.469

Review 7.  The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus.

Authors:  Saikat Dewanjee; Jayalakshmi Vallamkondu; Rajkumar Singh Kalra; Pratik Chakraborty; Moumita Gangopadhyay; Ranabir Sahu; Vijaykrishna Medala; Albin John; P Hemachandra Reddy; Vincenzo De Feo; Ramesh Kandimalla
Journal:  Cells       Date:  2021-05-28       Impact factor: 6.600

8.  Hyperglycemia aggravates acute liver injury by promoting liver-resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR-mediated autophagy induction.

Authors:  Qi Wang; Song Wei; Shun Zhou; Jiannan Qiu; Chenyu Shi; Rui Liu; Haoming Zhou; Ling Lu
Journal:  Immunol Cell Biol       Date:  2019-11-19       Impact factor: 5.126

Review 9.  Genetic and Epigenomic Modifiers of Diabetic Neuropathy.

Authors:  Milena Jankovic; Ivana Novakovic; Dejan Nikolic; Jasmina Mitrovic Maksic; Slavko Brankovic; Ivana Petronic; Dragana Cirovic; Sinisa Ducic; Mirko Grajic; Dragana Bogicevic
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

10.  Regulatory Effects of Astragaloside IV on Hyperglycemia-Induced Mitophagy in Schwann Cells.

Authors:  Xiaoyi Wei; Yalin Zheng; Yanke Ai; Buman Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-11       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.